|Day Low/High||287.01 / 293.90|
|52 Wk Low/High||208.34 / 305.45|
Bitcoin, the most famous of all crypto-currencies, has enjoyed something of a rebound of late.
The myriad names in oncology have been the hottest area for acquisitions along with gene therapy.
I think we can all agree that there will be no increase made to the Fed Funds Rate today.
Let's check the charts and indicators.
Analyst downgrades and mind-boggling P/E ratios do not matter in this current market.
This options strategy on SBUX offers potential reward with little risk.
The crash of oil will only accelerate the move.
There is likely more headline risk to our front than to our rear.
Who, out there in the health care sector, is safe?
It's hard to understand the magnitude of the change.
You can make a case to buy any of the stocks of the companies at ICR.
These lesser-known diagnostic and life sciences firms are involved in areas from genetic tools to telemedicine.
It looks like China is building again.
All the great stocks have artificial intelligence and e-commerce in common.
What's next for shares of Agilent Technology.
Thermo Fisher and McCormick deals show the true colors of stocks.
It's a wonder to me how split this market really is.
These big stocks are teetering on the edge of breakdown territory.
Value stocks will extend their outperformance over growth stocks that began last year.
Thermo Fisher Scientific and IHS Markit are both breaking out of tight patterns.